We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Should Look to 483s and Warnings for Lab Control Tips
Drugmakers Should Look to 483s and Warnings for Lab Control Tips
To avoid getting cited for poor laboratory controls when FDA investigators come calling, manufacturers should study the mistakes made by their peers, one expert says.